Kelan Hlavaty
Senior Director, Head of Analytical Development & Quality Control eGenesis Bio
Kelan Hlavaty leads analytical development and quality control at eGenesis, advancing genetically engineered pigs for xenotransplantation. He oversees development of assays to characterize extensive genome edits, including multiple human transgenes and antigen knockouts, with rigorous on- and off-target analysis across DNA, RNA, protein, and functional levels. Kelan directs analytical strategies supporting regulatory submissions and clinical readiness, establishing robust testing frameworks to ensure the safety, consistency, and quality of complex engineered donor organs.
Seminars
Wednesday 30th September 2026
Applying Genome Editing to Xenotransplantation to Advance Human Compatible Organ Solutions
3:45 pm
- Investigating how genome editing is being used to make porcine organs compatible with humans to give you insight into one of the most pioneering clinical translation applications in the field
- Mapping the regulatory and safety considerations specific to xenotransplantation programs to help you understand the unique challenges of translating genome editing into organ compatibility
- Highlighting real-world progress in xenotransplantation to equip you with a broader perspective on how genome editing is expanding the boundaries of therapeutic application
